Prenatal and childhood exposure to bisphenols and bone mineral density in 7-year-old children from the Odense Child Cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,84 MB, PDF-dokument

  • Annika Sigvaldsen
  • Hanne Frederiksen
  • Frederik Damsgaard Højsager
  • Anna Maria Andersson
  • Juul, Anders
  • Henriette Boye
  • Marianne Skovsager Andersen
  • Tina Kold Jensen
Background
Bisphenol A (BPA) is a well-known endocrine disrupter used in several consumer products. Restricted use of BPA has led to increased use of bisphenol F (BPF) and bisphenol S (BPS). While previous studies found no associations between prenatal BPA and BPF exposure and bone mineral density (BMD), two recent cohort studies found that prenatal BPS exposure was negatively associated with bone mineral density in the offspring.

Aim
To determine possible associations between maternal and child urinary bisphenol concentrations, BMD and bone mineral content (BMC) in 7-year-old healthy children.

Methods
Pregnant women were recruited in 2010–2012 to participate in the Odense Child Cohort (OCC), Denmark. Maternal urine samples were collected in gestational week 28 and urinary BPA concentration was measured by isotope diluted LC-MS/MS. The children delivered a urine sample at age 7 years in which BPA, BPF and BPS were measured by an extended LS-MS/MS method based on the original method. At age 7 years DXA scans were performed and BMC and Z-score for BMD calculated. Associations between osmolality adjusted urinary maternal BPA and child BPA, BPF and BPS concentrations and BMC and BMD Z-score were examined by multiple linear regression analysis adjusted for potential confounders. Additionally, a combined effect of the bisphenols were evaluated by including the sum of child urinary BPA, BPF and BPS concentrations in the statistical analyses.

Results
A total of 546 mothers and 453 children aged 7 years participated. BPA was detected in 84% and 96% of the maternal and child urine samples, respectively. We found no significant association between maternal urinary BPA concentration during pregnancy and BMC and BMD Z-score in 7-year-old children. In addition, no association between current bisphenol exposure in tertiles and bone density was found, interestingly, current BPA and summed bisphenol exposure in the highest 10% was associated with lower BMD Z-score at age 7-years, statistically significant for boys.

Conclusion
In these low exposed children we found no association between prenatal or current bisphenol exposure in tertiles and BMD in healthy children, however, the highest 10% exposed children had lower BMD, significant for boys, suggesting a negative impact with high bisphenol exposure. The short half-lives of bisphenols and the cross-sectional nature of the child exposure prompt more longitudinal studies to further clarify this topic.
OriginalsprogEngelsk
Artikelnummer114408
TidsskriftInternational Journal of Hygiene and Environmental Health
Vol/bind260
Antal sider10
ISSN1438-4639
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
This work was supported by Odense University Hospital, Denmark, the Region of Southern Denmark, The Municipality of Odense, Denmark, The University of Southern Denmark, the Mental Health Service of the Region of Southern Denmark, Open Patient data Exploratory Network (OPEN), Denmark, Danish National Centre for Endocrine Disrupters (MST-611-00012), Independent Research Fund Denmark (4004-00352 B_FSS), Novo Nordisk Foundation, Denmark (grant no. NNF19OC0058266 and NNF17OC0029404), European Human Biomonitoring Initiative (HBM4EU), Sygeforsikring \u201Cdanmark\u201D (journalnr. 2021\u20130173), the Collaborative foundation between Odense University Hospital and Rigshospitalet, Helsefonden and the Danish Mental Health Fund. The LS-MS/MS equipment was financially supported by the Velux Foundation, Denmark.

Funding Information:
This work was supported by Odense University Hospital, Denmark, the Region of Southern Denmark, The Municipality of Odense, Denmark, The University of Southern Denmark, the Mental Health Service of the Region of Southern Denmark, Odense Patient data Exploratory Network (OPEN), Denmark, The Danish Center for Hormone Disrupting Chemicals (MST-611-00012), The Danish Research Council (4004-00352B_FSS), Novo Nordisk Foundation, Denmark (grant no. NNF19OC0058266 and NNF17OC0029404), HBM4EU, Sygeforsikring Danmark (journalnr. 2021-0173), the Collaborative foundation between Odense University Hospital and Rigshospitalet, Helsefonden and the Danish Mental Health Fund. The LS-MS/MS equipment was financially supported by the Velux Foundation.

Publisher Copyright:
© 2024 The Authors

ID: 395865912